SAVA - Spark Newswire

3 minute read

Mid-Morning Market Update: Markets Edge Higher; Dick’s Sporting Goods Beats Q2 Views

Today, 10:37 AM

Following the market opening Wednesday, the Dow traded up 0.07% to 35,389.32 while the NASDAQ rose 0.17% to 15,045.45. The S&P also rose, gaining 0.14% to 4,492.57.

DKS

1 minute read

Trading Ideas

Top 20 Trending Stocks On WallStreetBets As Of Wednesday Aug. 25, 2021 (Via Swaggy Stocks)

By Michael Horton

Today, 10:37 AM

Data from https://swaggystocks.com/dashboard/wallstreetbets/ticker-sentiment GameStop (GME) AMC Entertainment (AMC) Alibaba (BABA) BlackBerry (BB) Clover Health Investments (CLOV) ContextLogic (WISH) Nvidia

AAPL

2 minute read

Cassava Sciences Shares Sink With Alzheimer’s Drug Mired In Controversy

By Shanthi Rexaline

Today, 10:37 AM

Neurodegenerative diseases-focused biopharma Cassava Sciences, Inc. (NASDAQ: SAVA) saw both sides of the world Tuesday.

SAVA

1 minute read

News

Why Cassava Sciences’ Stock Is Getting Hammered Today

By Randy Elias

Today, 10:37 AM

Cassava Sciences, Inc. (NASDAQ: SAVA) shares are trading lower on negative claims that were posted online yesterday after market hours. The company issued a response to the claims today, saying they believe the claims regarding scientific integrity are false and misleading.

SAVA

1 minute read

12 Health Care Stocks Moving In Wednesday’s Pre-Market Session

By Benzinga Insights

Today, 10:37 AM

BLFS

4 minute read

The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer’s Drug

By Shanthi Rexaline

Today, 10:37 AM

ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24)

AGEN

3 minute read

21 Stocks Moving in Wednesday’s Pre-Market Session

By Lisa Levin

Today, 10:37 AM

Gainers Regencell Bioscience Holdings Limited (NASDAQ: RGC) rose 40.1% to $21.43 in pre-market trading after gaining over 11% on Tuesday. Regencell Bioscience recently reported partial exercise of underwriter’s over-allotment option.

ACST

4 minute read

News

Cassava Sciences Issues Response To Negative Claims Made Online

By Bill Haddad

Today, 10:37 AM

Cassava Sciences, Inc. (NASDAQ:SAVA), a biotechnology company focused on Alzheimer's disease, today issued a response to claims that were posted on-line yesterday after market hours. Cassava Sciences believes the

SAVA

1 minute read

Cassava Sciences Receives FDA’s Special Protocol Assessment For Alzheimer’s Trials

By Vandana Singh

Today, 10:37 AM

Cassava Sciences Inc (NASDAQ:SAVA) announced an agreement with the FDA under a Special Protocol Assessment (SPA) for both of its pivotal…

SAVA

1 minute read

Legal
News

Cassava Sciences Granted U.S. Patent Titled ‘Cocrystals of naloxone and naltrexone’

By Benzinga Newsdesk

Today, 10:37 AM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6590&f=G&l=50&d=PTXT&p=132&S1=20210824&OS=20210824&RS=20210824

SAVA

Feed Symbols: SAVA